Abundant circulating lipids - a new opportunity for NSCLC detection?

Nat Rev Clin Oncol. 2022 Jun;19(6):361-362. doi: 10.1038/s41571-022-00621-5. Epub 2022 Mar 28.

Authors

Markus R Wenk¹, Hyungwon Choi²

Affiliations

¹ Department of Biochemistry and Precision Medicine Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. bchmrw@nus.edu.sg.
² Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. hyung_won_choi@nus.edu.sg.

PMID: 35351993
DOI: 10.1038/s41571-022-00621-5

No abstract available

Publication types

Comment

MeSH terms

Biomarkers, Tumor / genetics
Carcinoma, Non-Small-Cell Lung* / diagnosis
Carcinoma, Non-Small-Cell Lung* / drug therapy
Carcinoma, Non-Small-Cell Lung* / genetics
Humans
Lipids
Lung Neoplasms* / diagnosis

Substances

Biomarkers, Tumor
Lipids